Gene · 3977
Papers2,592
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,261 to 1,280 of 2,592
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Historical overview of the interleukin-6 family cytokine. | J Exp Med | 2020 | 32267936 | PubTator, text mining | PubMed |
| Knockdown of Musashi RNA Binding Proteins Decreases Radioresistance but Enhances Cell Motility and Invasion in Triple-Negative Breast Cancer. | Int J Mol Sci | 2020 | 32245259 | PubTator, text mining | PubMed |
| Mother and Embryo Cross-Communication. | Genes (Basel) | 2020 | 32244282 | PubTator, text mining | PubMed |
| miR-204-5p Suppress Lymph Node Metastasis via Regulating CXCL12 and CXCR4 in Gastric Cancer. | J Cancer | 2020 | 32231725 | PubTator, text mining | PubMed |
| Implication of the p53-Related miR-34c, -125b, and -203 in the Osteoblastic Differentiation and the Malignant Transformation of Bone Sarcomas. | Cells | 2020 | 32230926 | PubTator, text mining | PubMed |
| Idiopathic brain calcification in a patient with hereditary hemochromatosis. | BMC Neurol | 2020 | 32228506 | PubTator, text mining | PubMed |
| Study of the Association Between microRNA (miR-25T>C, miR-32C>A, miR-125C>T, and miR-222G>T) Polymorphisms and the Risk of Recurrent Pregnancy Loss in Korean Women. | Genes (Basel) | 2020 | 32224893 | PubTator, text mining | PubMed |
| Advances in cancer cachexia: Intersection between affected organs, mediators, and pharmacological interventions. | Biochim Biophys Acta Rev Cancer | 2020 | 32222610 | PubTator, text mining | PubMed |
| EC330, a small-molecule compound, is a potential novel inhibitor of LIF signaling. | J Mol Cell Biol | 2020 | 32221559 | PubTator, text mining | PubMed |
| Integrated analysis of transcriptome profiling predicts potential lncRNA and circRNA targets in human nasopharyngeal carcinoma. | Oncol Lett | 2020 | 32218863 | PubTator, text mining | PubMed |
| miRNAs as potential biomarkers for the progression of gastric cancer inhibit CREBZF and regulate migration of gastric adenocarcinoma cells. | Int J Med Sci | 2020 | 32218690 | PubTator, text mining | PubMed |
| Prominence of IL6, IGF, TLR, and Bioenergetics Pathway Perturbation in Lung Tissues of Scleroderma Patients With Pulmonary Fibrosis. | Front Immunol | 2020 | 32210969 | PubTator, text mining | PubMed |
| MiRNAs in the Peri-Implantation Period: Contribution to Embryo-Maternal Communication in Pigs. | Int J Mol Sci | 2020 | 32210170 | PubTator, text mining | PubMed |
| Epigenetic modulations of noncoding RNA: a novel dimension of Cancer biology. | Mol Cancer | 2020 | 32209098 | PubTator, text mining | PubMed |
| Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome. | J Exp Med | 2020 | 32207811 | PubTator, text mining | PubMed |
| Integrative analysis of dysregulated lncRNA-associated ceRNA network reveals potential lncRNA biomarkers for human hepatocellular carcinoma. | PeerJ | 2020 | 32201648 | PubTator, text mining | PubMed |
| Molecular Simulation of Oncostatin M and Receptor (OSM-OSMR) Interaction as a Potential Therapeutic Target for Inflammatory Bowel Disease. | Front Mol Biosci | 2020 | 32195265 | PubTator, text mining | PubMed |
| In vitro Models of Breast Cancer Metastatic Dormancy. | Front Cell Dev Biol | 2020 | 32195244 | PubTator, text mining | PubMed |
| Management of Cancer Cachexia: Attempting to Develop New Pharmacological Agents for New Effective Therapeutic Options. | Front Oncol | 2020 | 32195193 | PubTator, text mining | PubMed |
Identification of candidate RNA signatures in triple-negative breast cancer by the construction of a competing endogenous RNA network with integrative analyses of Gene Expression Omnibus and The Cancer Genome Atlas data. | Oncol Lett | 2020 | 32194687 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3977/papers?page=64